- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (1656)
- Timeline of Article Publication (5)
- Authors Evaluation (2)
- Article Quality Tracking (2)
- Reference Citation Analysis (4)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2510)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2023 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang XS, Zhou HC, Wei P, Chen L, Ma WH, Ding L, Liang SC, Chen BD. Combined TIM-3 and PD-1 blockade restrains hepatocellular carcinoma development by facilitating CD4+ and CD8+ T cell-mediated antitumor immune responses. World J Gastrointest Oncol 2023; 15(12): 2138-2149 [PMID: 38173440 DOI: 10.4251/wjgo.v15.i12.2138] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i12/2138.htm |
| Number | Citing Articles |
| 1 |
Runzhi Wang, Rong Zhao, Zhongguo Liang, Kaihua Chen, Xiaodong Zhu. A Nomogram Based on Platelet Distribution Width-to-Lymphocyte Ratio to Predict Overall Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma. Journal of Inflammation Research 2024; : 4297 doi: 10.2147/JIR.S462833
|
| 2 |
Muhammad Naveed Khan, Binli Mao, Juan Hu, Mengjia Shi, Shunyao Wang, Adeel Ur Rehman, Xiaosong Li. Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1472430
|
| 3 |
Y. Moskalenko . Biological mechanisms of resistance to immune checkpoint inhibitors and overcoming this resistance: Challenges in medical oncology . Regulatory Mechanisms in Biosystems 2024; 15(1): 83 doi: 10.15421/022412
|